SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news

 

 

Increased intake of long-chain omega-3 may reduce diabetes risk: Study

By Nathan Gray+

21-Jan-2014
Last updated on 21-Jan-2014 at 15:33 GMT2014-01-21T15:33:49Z

Increased intake of long-chain omega-3 may reduce diabetes risk: Study

High serum concentrations of long-chain omega-3 fatty acids could help to reduce the risk of developing type 2 diabetes by up to a third, according to new population data.

The research, published in Diabetes Care, investigated the associations between serum omega-3 polyunsaturated fatty acids (PUFAs) including eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA) and the later risk of developing type 2 diabetes in middle-aged and older Finnish men.

Led by Dr Jyrki Virtanen from the University of Eastern Finland, the research team analysed data from more than 2,000 men - finding that the risk of developing diabetes was 33% lower for the of quarter of men with the highest serum concentrations of  EPA, DPA and DHA  when compared to the quarter with the lowest serum concentrations.

"No statistically significant associations were observed with serum or dietary ALA, dietary fish or EPA + DHA, or hair mercury," wrote Virtanen and his colleagues.

Study details

The team noted that previous research investigating whether fish consumption - or indeed omega-3 status - has any effect on the risk of developing type 2 diabetes has been 'highly contradictory'.

Indeed, a protective link has mainly been observed in Asian populations, whereas a similar associations have not been observed in studies conducted in Europe or the US - with some studies even linking high consumption of fish to increased diabetes risk.

Virtanen and his colleagues used data from the ongoing Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) analyse the associations between serum omega-3 fatty acid concentrations and onset of diabetes after approximately 20 years follow up in 2,212 men.

During an average follow-up of 19.3 years the team identified 422 men who had been diagnosed with type 2 diabetes. Serum long-chain omega-3 fatty acid concentrations of all 2,212 men were divided in to quartiles, and then analysed for any differences in rate of onset.

Men with the highest serum concentrations of EPA, DPA and DHA, were found to have 33% lower risk of developing type 2 diabetes than those with the lowest concentrations. However, no statistically significant associations were observed with serum or dietary ALA, dietary fish, or measure of EPA plus DHA.

"Serum long-chain omega-3 PUFA concentration, an objective biomarker for fish intake, was associated with long-term lower risk of type 2 diabetes," the team concluded.

Source: Diabetes Care
Volume 37, Number 1, Pages 189-196, doi: 10.2337/dc13-1504
"Serum Omega-3 Polyunsaturated Fatty Acids and Risk of Incident Type 2 Diabetes in Men: The Kuopio Ischaemic Heart Disease Risk Factor Study"
Authors: Jyrki K. Virtanen, Jaakko Mursu, et al

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars